QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer

NCT07205497 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Immunotherapy
Locally Advanced Cervical Cancer

Interventions

DRUG: QL1706+TC

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University